Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2004
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
07/21/2004CN1514843A Somatostatin-dopamine chimeric analogs
07/21/2004CN1514834A Cyclohexylphenyl vasopression agonists
07/21/2004CN1514829A Novel herbicides
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1513452A Use of CGMP phosphodiesterase inhibitor for treating sexual impotence
07/21/2004CN1158282C Camptothecine like compound, its preparing method and medicinal composition containing them
07/21/2004CN1158281C 1-aryl-1,8-naphthylidine-4-one derivative as type IV phosphodiesterase inhibitor
07/21/2004CN1158278C Sulfamoyl compounds and agricultural or horticultural bactericide
07/20/2004US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
07/20/2004US6765008 Pyrrolopyrimidines as CRF antagonists
07/15/2004WO2004058776A1 Therapeutic agents
07/15/2004WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
07/15/2004WO2004058762A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
07/15/2004WO2004058761A1 Pyrazole compounds as integrin receptor antagonists derivatives
07/15/2004WO2004058760A1 Thiazole compounds as integrin receptor antagonists derivatives
07/15/2004WO2004058759A1 Aryl / hetaryl substituted imidazoquinolines
07/15/2004WO2004058758A1 Synthesis of heteroaryl acetamides
07/15/2004WO2004058757A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
07/15/2004WO2004058756A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
07/15/2004WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
07/15/2004WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
07/15/2004WO2004058727A1 Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
07/15/2004WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
07/15/2004WO2004058704A2 Quinazolinones as potassium channel modulators
07/15/2004WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
07/15/2004WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058176A2 Acyclic pyrazole compounds
07/15/2004WO2004058144A2 Antibacterial agents
07/15/2004WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
07/15/2004WO2004039318A3 Anti-infective biaryl compounds
07/15/2004WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases
07/15/2004WO2004006846A3 Receptor-type kinase modulators and methods of use
07/15/2004US20040138459 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
07/15/2004US20040138454 Drugs for treating pain formed by arylation
07/15/2004US20040138451 Epindolidione pigments
07/15/2004US20040138447 Nonhygroscopic heterocyclic amine hydrate containg compound as antidepressant formed by drying and crystals in air
07/15/2004US20040138292 4-Aminomethyl-3-alkoxyiminopyrrolidinium dimethanesulfonate; bactericides
07/15/2004US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
07/15/2004US20040138276 Metalloproteinase inhibitors
07/15/2004US20040138249 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
07/15/2004US20040138248 adjustment immunology response; induce biosynthesis of cytokines; viricides; anticancer agents
07/15/2004US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138202 Tetracyclic azepinoindole compounds
07/15/2004US20040138200 Pharmaceutical compositions for treatment of Parkinson's disease
07/15/2004US20040138195 Activation using enzyme or ionizing radiation
07/15/2004US20040137069 Pirenzepine ophthalmic gel
07/15/2004US20040135125 Antiscaling agents
07/15/2004US20040135124 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
07/15/2004CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/15/2004CA2510375A1 Aryl / hetaryl substituted imidazoquinolines
07/15/2004CA2510298A1 Acyclic pyrazole compounds
07/15/2004CA2510084A1 Thiazole compounds as integrin receptor antagonists derivatives
07/15/2004CA2509565A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
07/15/2004CA2509561A1 Synthesis of heteroaryl acetamides
07/15/2004CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
07/15/2004CA2508917A1 Therapeutic agents
07/15/2004CA2507958A1 Pyrazole compounds as integrin receptor antagonists derivatives
07/14/2004EP1436293A1 Polycyclic compounds having anti-tumor activity
07/14/2004EP1436292A1 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists
07/14/2004EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor
07/14/2004EP1436266A2 Methods and compositions of novel triazine compounds
07/14/2004EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435952A1 8-amino- 1,2,4]triazolo 1,5-a]pyridine-6-carboxylic acid amide
07/14/2004EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
07/14/2004EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
07/14/2004EP1235803B1 Urea compounds having muscarinic receptor antagonist activity
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP1214321B1 Process for production of naphthyridine-3-carboxylic acid derivatives
07/14/2004CN1513173A Optical data carrier containing a cyclizable compound in the information layer
07/14/2004CN1512883A Crf受体拮抗剂 Crf receptor antagonist
07/14/2004CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor
07/14/2004CN1157115C Antifungal active compound compsns.
07/13/2004US6762301 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
07/13/2004US6762194 Quinolinone derivatives
07/13/2004US6762192 Useful in therapy and prophylaxis of epilepsy, migraine, and other disorders
07/13/2004US6762177 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
07/13/2004US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid
07/13/2004CA2158354C Use of granisetron for the treatment of post-operative nausea and vomiting
07/08/2004WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/08/2004WO2004056829A1 Fungicides based on nitrogen-containing heterocycles
07/08/2004WO2004056826A1 Fungicides
07/08/2004WO2004056825A1 Pyridodiazines as plant fungicides
07/08/2004WO2004056824A2 Naphthyridine derivatives and their use as fungicides
07/08/2004WO2004056823A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
07/08/2004WO2004056822A1 Pyridino `2, 3-d! pyrimidine derivatives as selective kdr and fgfr inhibitors
07/08/2004WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments
07/08/2004WO2004056781A1 Processes for preparing quinolonecarboxylate derivatives
07/08/2004WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
07/08/2004WO2004056727A2 Process of making chalcone derivatives
07/08/2004WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders
07/08/2004WO2004056362A2 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines
07/08/2004WO2004056324A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists